Phase 2 Trial Enrolling: Combination Therapy for Metastatic Castration-Resistant Prostate Cancer

Phase 1 Enrolling: Sylvester Cancer Center Launches Innovative Clinical Trial for High-Grade Neuroendocrine Tumors